METTL3 and cancer: However, ruxolitinib could not suppress the effect of METTL3 depletion-mediated VSV-ΔM51 inhibition when it was added only post-infection (Fig. 5B and C), suggesting that cancer cells were in a fully active and irreversible intrinsic antiviral state before infection.